Cointime

Kiadis Pharma

company

About

Kiadis Pharma is a biopharmaceutical company offering novel treatment options for terminally ill cancer patients.

  • 51 - 100

Highlights

Total Funding Amount
€60M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€10M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
€60M
Kiadis Pharma has raised a total of €60M in funding over 2 rounds. Their latest funding was raised on Aug 1, 2018 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2018 Post-IPO Debt €20M 1 Kreos Capital — Detail
Aug 17, 2017 Post-IPO Debt €15M 1 Kreos Capital — Detail
Nov 20, 2012 Series Unknown €10M 1 — — Detail
Jun 26, 2007 Series Unknown €15M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Kiadis Pharma is funded by 3 investors. Kreos Capital and Molten Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Kreos Capital Yes Post-IPO Debt
Molten Ventures — Series Unknown
MedSciences Capital — Series Unknown
Cointime
เนื้อหา
บริษัท